Works by Jain, Michael D.

Results: 24
    1

    Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01579-w
    By:
    • Sesques, Pierre;
    • Kirkwood, Amy A.;
    • Kwon, Mi;
    • Rejeski, Kai;
    • Jain, Michael D.;
    • Di Blasi, Roberta;
    • Brisou, Gabriel;
    • Gros, François-Xavier;
    • le Bras, Fabien;
    • Bories, Pierre;
    • Choquet, Sylvain;
    • Rubio, Marie-Thérèse;
    • Iacoboni, Gloria;
    • O'Reilly, Maeve;
    • Casasnovas, René-Olivier;
    • Bay, Jacques-Olivier;
    • Mohty, Mohamad;
    • Joris, Magalie;
    • Abraham, Julie;
    • Castilla Llorente, Cristina
    Publication type:
    Article
    2

    The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.

    Published in:
    Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01465-x
    By:
    • Rejeski, Kai;
    • Hansen, Doris K.;
    • Bansal, Radhika;
    • Sesques, Pierre;
    • Ailawadhi, Sikander;
    • Logue, Jennifer M.;
    • Bräunlein, Eva;
    • Cordas dos Santos, David M.;
    • Freeman, Ciara L.;
    • Alsina, Melissa;
    • Theurich, Sebastian;
    • Wang, Yucai;
    • Krackhardt, Angela M.;
    • Locke, Frederick L.;
    • Bachy, Emmanuel;
    • Jain, Michael D.;
    • Lin, Yi;
    • Subklewe, Marion
    Publication type:
    Article
    3

    Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 6, p. 1196, doi. 10.1002/ajh.27305
    By:
    • Caprice, Teresa;
    • Fan, Wenyi;
    • Kim, Jongphil;
    • Faramand, Rawan;
    • Mishra, Asmita;
    • Perez, Lia;
    • Khimani, Farhad;
    • Lazaryan, Aleksandr;
    • Ochoa‐Bayona, Jose L.;
    • Liu, Hien;
    • Jain, Michael D.;
    • Nieder, Michael;
    • Anasetti, Claudio;
    • Nishihori, Taiga;
    • Pidala, Joseph A.;
    • Bejanyan, Nelli;
    • Elmariah, Hany
    Publication type:
    Article
    4

    The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
    By:
    • Rejeski, Kai;
    • Wang, Yucai;
    • Albanyan, Omar;
    • Munoz, Javier;
    • Sesques, Pierre;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Ries, Isabelle;
    • Bücklein, Veit L.;
    • Mohty, Razan;
    • Dreyling, Martin;
    • Baluch, Aliyah;
    • Shah, Bijal;
    • Locke, Frederick L.;
    • Hess, Georg;
    • Barba, Pere;
    • Bachy, Emmanuel;
    • Lin, Yi;
    • Subklewe, Marion;
    • Jain, Michael D.
    Publication type:
    Article
    5
    6
    7
    8

    Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 753, doi. 10.1016/j.clml.2022.05.004
    By:
    • Jacobs, Miriam T.;
    • Jain, Michael D.;
    • Gao, Feng;
    • Nastoupil, Loretta J.;
    • Spiegel, Jay Y.;
    • Lin, Yi;
    • Dahiya, Saurabh;
    • Lunning, Matthew;
    • Lekakis, Lazaros;
    • Reagan, Patrick M.;
    • Oluwole, Olalekan O.;
    • McGuirk, Joseph;
    • Deol, Abhinav;
    • Sehgal, Alison;
    • Goy, Andre;
    • Hill, Brian T.;
    • Andreadis, Charalambos;
    • Munoz, Javier;
    • Chavez, Julio C.;
    • Bennani, N. Nora
    Publication type:
    Article
    9
    10
    11

    Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.

    Published in:
    Cardio-Oncology, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40959-023-00170-5
    By:
    • Lee, Dae Hyun;
    • Chandrasekhar, Sanjay;
    • Jain, Michael D.;
    • Mhaskar, Rahul;
    • Reid, Kayla;
    • Lee, Sae Bom;
    • Corallo, Salvatore;
    • Hidalgo-Vargas, Melanie J.;
    • Kumar, Abhishek;
    • Chavez, Julio;
    • Shah, Bijal;
    • Lazaryan, Aleksandr;
    • Khimani, Farhad;
    • Nishihori, Taiga;
    • Bachmeier, Christina;
    • Faramand, Rawan;
    • Fradley, Michael G.;
    • Jeong, Daniel;
    • Oliveira, Guilherme H.;
    • Locke, Frederick L.
    Publication type:
    Article
    12

    Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation.

    Published in:
    Open Forum Infectious Diseases, 2024, v. 11, n. 10, p. 1, doi. 10.1093/ofid/ofae564
    By:
    • Handley, Guy;
    • Yepes, Amanda;
    • Eliassen, Eva;
    • Dominguez, Gabriel;
    • Pasikhova, Yanina;
    • Klinkova, Olga;
    • Baluch, Aliyah;
    • Febres-Aldana, Anthony J;
    • Alsina, Melissa;
    • Elmariah, Hany;
    • Khimani, Farhad;
    • Hansen, Doris K;
    • Freeman, Ciara L;
    • Jain, Michael D;
    • Locke, Frederick;
    • Lazaryan, Aleksandr;
    • Liu, Hein D;
    • Mishra, Asmita;
    • Mirza, Abu-Sayeef;
    • Nishihori, Taiga
    Publication type:
    Article
    13

    Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 6, p. 1936, doi. 10.1002/cam4.3664
    By:
    • Hoogland, Aasha I.;
    • Jayani, Reena V.;
    • Collier, Aaron;
    • Irizarry‐Arroyo, Nathaly;
    • Rodriguez, Yvelise;
    • Jain, Michael D.;
    • Booth‐Jones, Margaret;
    • Hyland, Kelly A.;
    • James, Brian W.;
    • Barata, Anna;
    • Bachmeier, Christina A.;
    • Chavez, Julio C.;
    • Khimani, Farhad;
    • Krivenko, Gabriel S.;
    • Lazaryan, Aleksandr;
    • Liu, Hien D.;
    • Nishihori, Taiga;
    • Pinilla‐Ibarz, Javier;
    • Shah, Bijal D.;
    • Abidi, Muneer
    Publication type:
    Article
    14
    15
    16

    Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 8, p. 3904, doi. 10.3390/ijms26083904
    By:
    • Mokhtari, Sepideh;
    • Asquith, Justin M.;
    • Kareem, Syeda Saba;
    • Bachmeier, Christina A.;
    • Pina, Yolanda;
    • Faramand, Rawan G.;
    • Kim, Youngchul;
    • Peguero, Edwin N.;
    • Sahebjam, Solmaz;
    • Jaffer, Mohammad H.;
    • Iacono, David P.;
    • Jain, Michael D.;
    • Vogelbaum, Michael A.;
    • Davila, Marco L.;
    • Forsyth, Peter A.;
    • Locke, Frederick L.;
    • Lazaryan, Aleksandr
    Publication type:
    Article
    17
    18
    19
    20

    Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy.

    Published in:
    Psycho-Oncology, 2021, v. 30, n. 8, p. 1294, doi. 10.1002/pon.5674
    By:
    • Barata, Anna;
    • Hoogland, Aasha I.;
    • Hyland, Kelly A.;
    • Otto, Amy K.;
    • Kommalapati, Anuhya;
    • Jayani, Reena V.;
    • Irizarry‐Arroyo, Nathaly;
    • Collier, Aaron;
    • Rodriguez, Yvelise;
    • Welniak, Taylor L.;
    • Booth‐Jones, Margaret;
    • Logue, Jennifer;
    • Small, Brent J.;
    • Jain, Michael D.;
    • Reblin, Maija;
    • Locke, Frederick L.;
    • Jim, Heather S. L.
    Publication type:
    Article
    21
    22
    23
    24